Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma

For years, prospective randomized clinical trials excluded patients with non-conventional histologies of renal cell carcinoma (RCC). The paucity of data has led to adopting the same treatment strategies used for clear-cell RCC (ccRCC). In the present narrative review, we explored state of the art ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Bersanelli, Melissa, Rebuzzi, Sara Elena, Roviello, Giandomenico, Catalano, Martina, Brunelli, Matteo, Rizzo, Mimma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Immunotherapy - Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012923/
https://www.ncbi.nlm.nih.gov/pubmed/36758960
http://dx.doi.org/10.1080/21645515.2023.2171672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012923/
https://www.ncbi.nlm.nih.gov/pubmed/36758960
http://dx.doi.org/10.1080/21645515.2023.2171672

Ejemplares similares